Sophia genetics announces two million patient cases analyzed, marking a new milestone for data-driven medicine at nvidia gtc

Boston, ma and rolle, switzerland , march 18, 2025 /prnewswire/ -- sophia genetics (nasdaq: soph), a cloud-native software company and leader in data-driven medicine, has reached a historic milestone: more than two million patients genomic profiles analyzed on the ai-powered analytics platform sophia ddm™. this achievement solidifies sophia genetics as the gold-standard provider of actionable insights for patient care, applying ai capabilities shaped by an unmatched dataset of diverse, real-world patient data.
NVDA Ratings Summary
Quant
NVDA Quant Ranking
Sector
Industry
Quant Rating
Quant Score